SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SIBIA Neurosciences (SIBI) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (535)11/15/1999 11:38:00 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 579
 
Miljenko found this, hot off the presses........

jci.org

"In fact,
compounds that have been shown to reduce Aß peptide levels in transgenic mice are expected to reach the clinic soon."




To: scaram(o)uche who wrote (535)12/11/1999 4:08:00 AM
From: jayhawk969  Read Replies (3) | Respond to of 579
 
<filed today..... as I've indicated previously, I sold all of my shares, but........... go,
BVF, go>

Did any one else receive their letter that this case was settled for $18 MM (interesting in that amount was escrowed for the Cadus paten infringement case). How many shares were outstanding at the time of sale?

J.D.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News